Diphenylhexatriene as a Fluorescent Probe for Monitoring Low Density Lipoprotein Peroxidation

References

• Steinberg D. Metabolism of lipoproteins and their role in the pathogenesis of atherosclerosis. Atherosclerosis Reviews, J. Stokes, M. Mancini. Raven Press, New York 1988; 1–23
   Google Scholar
• Steinbrecher U. P., Zhang H., Lougheed M. Role of oxidatively modified low density lipoprotein in atherosclerosis. Free Radicals in Biology and Medicine 1990; 9: 155–168
   PubMed Web of Science ®Google Scholar
• Esterbauer H., Dieber-Rotheneder M., Waeg G., Striegl G., Jürgens D. Biochemical, structural and functional properties of oxidized low density lipoprotein. Chemical Research in Toxicology 1990; 3: 77–92
   PubMed Web of Science ®Google Scholar
• Henriksen T., Mahoney E. M., Steinberg D. Enhanced macrophage degradation of low density lipoprotein previously incubated with cultured endothelial cells: recognition by receptors for acetylated low density lipoprotein. Proceedings of the National Academy of Sciences USA 1981; 78: 6499–6503
   PubMed Web of Science ®Google Scholar
• Heinecke J. W., Rosen H., Chait A. Iron and copper promote modification of low density lipoprotein by human arterial smooth muscle cells in culture. Journal of Clinical Investigation 1984; 74: 1890–1894
   PubMed Web of Science ®Google Scholar
• Cathcart M. K., Morel D. W., Chisolm G. M. Monocytes and neutrophils oxidize low density lipoprotein making it cytotoxic. Journal of Leukocyte Biology 1985; 38: 341–350
   PubMed Web of Science ®Google Scholar
• Steinbrecher U. P., Parthasarathy S., Leake D. S., Witztum J. L., Steinberg D. Modification of low density lipoprotein by endothelial cells involves lipid peroxidation and degradation of low density lipoprotein phospholipids. Proceedings of the National Academy of Sciences USA 1984; 81: 3883–3887
   PubMed Web of Science ®Google Scholar
• Steinbrecher U. P. Oxidation of human low density lipoprotein results in derivatization of lysine residues of apolipoprotein B by lipid peroxide decomposition products. Journal of Biological Chemistry 1987; 262: 3603–3608
   PubMed Web of Science ®Google Scholar
• Palinski W., Rosenfeld M. E., Ylä-Herttuala S., Gurtner G. C., Socher S. S., Butler S. W., Parthasarathy S., Carew T. E., Steinberg D., Witztum J. L. Low density lipoprotein undergoes oxidative modification in vivo. Proceedings of the National Academy of Sciences USA 1989; 86: 1372–1376
   PubMed Web of Science ®Google Scholar
• Ylä-Herttuala S., Palinski W., Rosenfeld M. E., Parthasarathy S., Carew T. E., Butler S., Witztum J. L., Steinberg D. Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man. Journal of Clinical Investigation 1989; 84: 1086–1095
   PubMed Web of Science ®Google Scholar
• Quehenberger O., Koller E., Jürgens G., Esterbauer H. Investigation of lipid peroxidation in human low density lipoprotein. Free Radical Research Communications 1987; 3: 233–242
   PubMedGoogle Scholar
• Lenz M. L., Hughes H., Mitchell J. R., Via D. P., Guyton J. R., Taylor A. A., Gotto A. M., Smith C. V. Lipid hydroperoxy and hydroxy derivatives in copper-catalyzed oxidation of low density lipoprotein. Journal of Lipid Research 1990; 31: 1043–1050
   PubMed Web of Science ®Google Scholar
• Yagi K. Lipid peroxides and human diseases. Chemistry and Physics of Lipids 1987; 45: 337–351
   PubMed Web of Science ®Google Scholar
• Esterbauer H., Striegl G., Puhl H., Rotheneder M. Continuous monitoring of in vitro oxidation of human low density lipoprotein. Free Radical Research Communications 1989; 6: 67–75
   PubMed Web of Science ®Google Scholar
• Cominacini L., Garbin U., Davoli A, Micciolo R., Bosello O., Gaviraghi G., Scuro L. A., Pastorino A. M. A simple test for predisposition to LDL oxidation based on the fluorescence development during copper-catalysed oxidative modification. Journal of Lipid Research 1991; 32: 349–358
   PubMed Web of Science ®Google Scholar
• Havel R. J., Eder H. A., Bragdon J. H. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. Journal of Clinical Investigation 1955; 34: 1345–1353
   PubMed Web of Science ®Google Scholar
• Peterson G. A. A simplification of the protein assay of Lowry et al, which is more generally applicable. Analytical Biochemistry 1977; 83: 346–356
   PubMed Web of Science ®Google Scholar
• Duportail G., Weinreb A. Photochemical changes of fluorescent probes in membranes and their effect on the observed fluorescence anisotropy. Biochimica Biophysica Acta 1983; 736: 171–177
   PubMedGoogle Scholar
• Esterbauer H., Dieber-Rotheneder M., Striegl G., Waeg G. Role of vitamin E in preventing the oxidation of low density lipoprotein. American Journal of Clinical Nutrition 1991; 53: 314S–321S
   PubMed Web of Science ®Google Scholar
• Parthasarathy S., Young S. G., Witztum J. L., Pittman R. C., Steinberg D. Probucol inhibits oxidative modification of low density lipoprotein. Journal of Clinical Investigation 1986; 77: 641–644
   PubMed Web of Science ®Google Scholar
• Breugnot C., Mazière C., Salmon S., Auclair M., Santus R., Morlière P., Lenaers A., Mazière J. C. Phenothiazines inhibit copper and endothelial cell-induced peroxydation of low density lipoprotein. Biochemical Pharmacology 1990; 40: 1975–1980
   PubMed Web of Science ®Google Scholar
• Breugnot C, Mazière C., Salmon S., Auclair M., Santus R., Morlière P., Lenaers A., Mazière J. C. Calcium antagonists prevent monocyte and endothelial cell-induced modification of low density lipoproteins. Free Radical Research Communications 1991; 15: 91–100
   PubMed Web of Science ®Google Scholar
• Jialal I., Freeman D. A., Grundy S. M. Varying susceptibility of different low density lipoproteins to oxidative modification. Arteriosclerosis and Thrombosis 1991; 11: 482–488
   PubMed Web of Science ®Google Scholar
• Jessup W., Rankin M. S., DeWhalley V. C., Hoult R. S., Scott J. Alpha-tocopherol consumption during low density lipoprotein oxidation. Biochemical Journal 1990; 265: 399–405
   PubMed Web of Science ®Google Scholar
• Shinitzky M., Barenholz Y. Fluidity parameters of lipid regions determined by fluorescence polarization. Biochimica Biophysica Acta 1978; 515: 367–394
   PubMed Web of Science ®Google Scholar
• Shinitzky M. Membrane lipid fluidity at a physiological relevant scale. Physical Methods on Biological Membranes and Their Model Systems, F. Conti, W. E. Blumberg, J. de Gier, F. Pocchiari. NATO ASI Series A, Plenum Press, New York 1985; Vol. 71: 227–243
   Google Scholar
• Parente R. A., Lentz B. R. Phase behavior of large unilamellar vesicles composed of synthetic phospholipids. Biochemistry 1984; 23: 2353–2362
   PubMed Web of Science ®Google Scholar
• Dachet C., Motta C., Neufcour D., Jacotot B. Fluidity changes and chemical composition of lipoproteins in type Ha hyperlipoproteinemia. Biochimica Biophysica Acta 1990; 1046: 64–72
   PubMedGoogle Scholar
• Bisby R. H., Cundall R. B., Davenport L., Johnson I. D., Thomas E. W. Diphenylhexatriene and some derivatives as fluorescent probes of membrane structures. Fluorescent Probes, G. S. Beddard, M. A. West. Academic Press, London 1981; 97–109
   Google Scholar